Answers are grounded in this paper and cite their sources.
Background/Objectives: We evaluated changes in body composition, metabolic parameters, and quality of life during liraglutide 3.0 mg treatment within a multimodal obesity-management programme and explored their association with participation in structured exercise. Methods: This prospective, non-randomised, real-world cohort included 70 adults with overweight or obesity receiving liraglutide and medical nutrition therapy 23 participated in the structured exercise group (SEG) and 47 in the non-structured exercise group (NSEG). Results: Sex-adjusted models showed significant changes over time in body weight, BMI, waist circumference, fat mass (FM), skeletal muscle mass (SMM) and several metabolic parameters, without significant time × group interactions for the main body-composition outcomes. Exploratory analyses showed different FM, FFM and SMM loss patterns per kilogram of total body-weight loss between groups (interaction p = 0.001, 0.004, and 0.014, respectively). Quality of life improved in several domains at 6 months. Conclusions: During liraglutide-based multimodal treatment, participants showed reductions in body weight and FM, together with favourable changes in several metabolic and quality-of-life measures. Absolute body composition trajectories were similar between groups, but exploratory analyses showed a different pattern in the composition of weight loss in SEG.
No takes yet. Share an insight, caveat, or question.
Macesic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: